Tiara Green, president, Accessia Health, explains how empowering trusted local leaders and involving communities early are ...

How the 2028 Medicare drug price negotiations will reshape market access, provider reimbursement, and patient care ...

A multi-national study reveals over half of older adults in several European countries are prescribed five or more ...

Subject matter experts share the challenges that patients face in terms of medication affordability, along with the role that ...

The Zensights Federated Healthcare Advisory Panel explores how shifting global dynamics are reshaping access and strategic planning across the healthcare system. The second day of Asembia’s AXS25 ...

Will Pih, co-founder, Two Labs, explains how specialty pharmacies and manufacturers are adapting to financial pressures in rare disease care through patient-centric services, hub innovation, and ...

The afternoon of day 2 at Asembia’s AXS25 Summit offered various intriguing sessions to pick from, including one on ...

Doug Long, VP, industry relations, IQVIA, examines shifting pharmaceutical trends, including specialty growth, biosimilar ...